Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo
about
THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell deathSulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.The protease inhibitor UCF-101 ameliorates streptozotocin-induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase.Omi/HtrA2 protease is associated with tubular cell apoptosis and fibrosis induced by unilateral ureteral obstructionCardiomyocyte death: mechanisms and translational implicationsPretreatment with low-dose gadolinium chloride attenuates myocardial ischemia/reperfusion injury in ratsMechanisms of cell death in heart disease.UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK.Cardiac Specific Overexpression of Mitochondrial Omi/HtrA2 Induces Myocardial Apoptosis and Cardiac Dysfunction.Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: Involvement of HtrA2/PED pathways in endothelial cells.Antidigoxin antiserum prevents endogenous digitalis-like compound-mediated reperfusion injury via modulating sodium pump isoform gene expression.The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.Extracellular matrix protein CCN1 regulates cardiomyocyte apoptosis in mice with stress-induced cardiac injury.Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway.
P2860
Q24318106-16BF1606-DFAB-4959-A7F8-69D388368FA0Q33772589-A06FE9DB-7E8B-4140-900C-717CFE01BE06Q33827744-05A5B3A2-A52C-47CC-B545-FE90AD588FF7Q33917799-9079D52A-BFA9-480D-98A6-4A8A28FDD3E0Q35657122-DD8EAC37-63B8-46CB-9103-65D27F05ADA2Q36765109-5E96BCBD-A8AA-4088-B5D7-4CD9B5DC8DA5Q37330076-46A281FB-E5D7-464E-93D6-37AAD4169834Q37391764-A7B03BB1-07C0-421E-A7FF-90F6890A2BA2Q37479622-72F218FE-261F-4322-9A1B-9DA443D12474Q39612983-A2CA1C3F-779A-47F5-A631-B7FB124EF0FBQ43174364-C75B8521-375C-46DF-B167-B2898FE42EFDQ50629649-9D83B86B-8608-4431-B472-C22B3A2272ABQ54456353-F488D906-FAF3-44DD-9C6D-8B1BC0015585Q55018020-420A530D-DB00-4366-858B-F8EFC4A94C96
P2860
Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo
description
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/02/28)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/02/28)
@nl
наукова стаття, опублікована в лютому 2007
@uk
مقالة علمية (نشرت في 28-2-2007)
@ar
name
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@ast
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@en
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@nl
type
label
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@ast
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@en
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@nl
prefLabel
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@ast
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@en
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@nl
P1476
Inhibition of HtrA2/Omi amelio ...... on injury in rat heart in vivo
@en
P2093
Kohji Fukunaga
Md Shenuarin Bhuiyan
P304
P356
10.1016/J.EJPHAR.2006.10.067
P407
P577
2007-02-28T00:00:00Z